🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking fines, legal action or prison.

Service Reaction and Material Removal

Based on TikTok, the service has removed violative material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.

Online Trading Activities

Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, filled with photos of weight loss, positive reviews and detailed guides for preparing or administering at residence.

Within moments of entering one group, a seller shared contact information, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or past usage.

Product Details and Costs

Inside these communities, posts show black plastic packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly significant medical dangers”.